Immunotherapy has proven to be one of the most exciting new areas for oncology and for our patients. These drugs have proven to be very effective in certain cancers (e.g. melanoma, lung cancer) but not in all. VCS is excited to open several new clinical trials using immunotherapy for patients that have either failed prior immunotherapy drugs or are interested in this approach for their cancers.
Currently we have several studies open across many tumor types using this approach.
In addition, we have other studies as well at other novel therapeutics as well for patients looking to explore treatments different than the standard, or looking for alternatives to standard chemotherapy. VCS currently runs a Phase 1 clinic with access to physicians with expertise in novel therapeutics, clinical trials, and personalized/genomic approaches to their care.